You have 9 free searches left this month | for more free features.

City

Nanjing (1)

Condition

Advanced Colorectal Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Jiangsu Cancer Institute & Hospital (1)

Collaborator

Intervention

bevacizumab、oxaliplatin、irinotecan、capecitabine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

bevacizumab、oxaliplatin、irinotecan、capecitabine

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Colorectal Cancer Trial in Nanjing (Bevacizumab?Oxaliplatin?Irinotecan?Capecitabine)

Recruiting

Advanced Colorectal Cancer

Bevacizumab、Oxaliplatin、Irinotecan、Capecitabine

Nanjing, Jiangsu, China

Jiangsu Cancer Institute & Hospital

Aug 27, 2021